December 22, 2011 -- Shunfeng Pharmaceutical, China’s largest external-use drugmaker, is auctioning itself off to the highest bidder. The minimum price? An even 600 million RMB ($95 million). There is dissension between Shunfeng’s minority shareholders and the company’s CEO. In addition, the company’s sales and profits are sliding lower. According to one insider, Sanjiu Medical and Pharma is the most likely to prevail in the auction. More details....
Stock Symbol: (SHE: 000999)
